These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6494575)

  • 21. Predicting response of human solid tumors to chemotherapy.
    Tanneberger S; Nissen E
    Cancer Treat Rev; 1983 Dec; 10(4):203-19. PubMed ID: 6362872
    [No Abstract]   [Full Text] [Related]  

  • 22. Coordinated surgical and drug treatment of cancer.
    Knock FE; Galt RM; Oester YT; Sylvester R; Haefliger R
    Int Surg; 1976 May; 61(5):287-92. PubMed ID: 931681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in vitro.
    Loo WT; Sasano H; Chow LW
    Biomed Pharmacother; 2007 Oct; 61(9):553-7. PubMed ID: 17905566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of drug resistance.
    Mader RM; Schmidt WM; Steger GG; Krupitza G
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):49-50. PubMed ID: 19203537
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical relevance of predictive tests for cancer chemotherapy.
    Mattern J; Volm M
    Cancer Treat Rev; 1982 Dec; 9(4):267-98. PubMed ID: 6762922
    [No Abstract]   [Full Text] [Related]  

  • 26. A phase II study of second-line neoadjuvant chemotherapy with capecitabine and radiation therapy for anthracycline-resistant locally advanced breast cancer.
    Gaui MF; Amorim G; Arcuri RA; Pereira G; Moreira D; Djahjah C; Biasoli I; Spector N
    Am J Clin Oncol; 2007 Feb; 30(1):78-81. PubMed ID: 17278899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer as analyzed by the human tumor stem cell assay.
    Sutherland CM; Mather FJ; Carter RD; Cerise EJ; Krementz ET
    Surgery; 1983 Aug; 94(2):370-5. PubMed ID: 6879450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human tumour cloning assay in the management of breast cancer patients.
    Dittrich C; Jakesz R; Wrba F; Havelec L; Haas O; Spona J; Holzner H; Kolb R; Moser K
    Br J Cancer; 1985 Aug; 52(2):197-203. PubMed ID: 4027163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics; 3. Methotrexate related malignant lymphoma].
    Tokuhira M; Kizaki M
    Nihon Naika Gakkai Zasshi; 2014 Jul; 103(7):1660-8. PubMed ID: 25154262
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
    Eidtmann H; Jonat W; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral capecitabine therapy: experience and developments at the Milano Cancer Institute].
    Longo F; Mansueto G
    Tumori; 2004; 90(1):suppl 17-27. PubMed ID: 15143996
    [No Abstract]   [Full Text] [Related]  

  • 32. Present status of chemosensitivity assays.
    Kern DH; Bertelsen CA
    Int Adv Surg Oncol; 1984; 7():187-213. PubMed ID: 6469373
    [No Abstract]   [Full Text] [Related]  

  • 33. [New cytostatics in oncological therapy].
    Osieka R; Seeber S; Bruntsch U; Gallmeier WM; Schmidt CG
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2468-74. PubMed ID: 4141307
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical significance of polyglutamylation in primary central nervous system lymphoma.
    Shinojima N; Fujimoto K; Makino K; Todaka K; Yamada K; Mikami Y; Oda K; Nakamura K; Jono H; Kuratsu JI; Nakamura H; Yano S; Mukasa A
    Acta Neuropathol Commun; 2018 Feb; 6(1):15. PubMed ID: 29475458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of experimental chemoendocrine therapy with a combination of a pure antiestrogen and 5-fluorouracil on human breast cancer cells implanted in nude mice.
    Ogasawara Y; Doihara H; Shiroma K; Kanaya Y; Shimizu N
    Surg Today; 1999; 29(2):149-56. PubMed ID: 10030740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A critical appraisal of the "human tumor stem-cell assay".
    Selby P; Buick RN; Tannock I
    N Engl J Med; 1983 Jan; 308(3):129-34. PubMed ID: 6336820
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer.
    Osako T; Ito Y; Ushijima M; Takahashi S; Tokudome N; Sugihara T; Iwase T; Matsuura M; Hatake K
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):865-71. PubMed ID: 18670777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay.
    Sondak VK; Bertelsen CA; Tanigawa N; Hildebrand-Zanki SU; Morton DL; Korn EL; Kern DH
    Cancer Res; 1984 Apr; 44(4):1725-8. PubMed ID: 6704978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
    Takashima T; Mukai H; Hara F; Matsubara N; Saito T; Takano T; Park Y; Toyama T; Hozumi Y; Tsurutani J; Imoto S; Watanabe T; Sagara Y; Nishimura R; Shimozuma K; Ohashi Y;
    Lancet Oncol; 2016 Jan; 17(1):90-8. PubMed ID: 26617202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of in vitro drug sensitivity of human tumor cells using [3H]thymidine incorporation in a modified human tumor stem cell assay.
    Friedman HM; Glaubiger DL
    Cancer Res; 1982 Nov; 42(11):4683-9. PubMed ID: 7127304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.